91̽��

Welcome to The Wallenberg Centre for Molecular and Translational Medicine yearly event! This year the theme is "Where research meets data science".

12.00 – 13.00 Lunch and poster session

Welcome and introduction to the Wallenberg Centre and Data Driven Life 91̽��
moderators: Aishe Sarshad & Martin Dalin

13:00 – 13:15 Introduction to the WCMTM – Christina Jern, Margit Mahlapuu and Julia Grönros

13:15 – 13:35 “The vision of University 91̽�� in the context of life science”, Carina Mallard, deputy vice chancellor,
and “The life science efforts within Region Västra Götaland”, Anders Carlberg, Head of Research and Innovation, Regional development, VGR

13:35 – 14:00 “Data-driven Life 91̽��” Siv Andersson, Knut and Alice Wallenberg Foundation
 

Bioinformatics – from data to insights
moderators: Aishe Sarshad & Martin Dalin

14:00 – 14:20 “Shining light on the cancer genome” Erik Larsson Lekholm, UGOT

14:20 – 14:35 “Glycans in Health: The Role of Machine Learning”– Daniel Bojar, WCMTM PI

14:35 – 14:50 Bioinformatics and translational medicine – Joan Camunas (over link), WCMTM PI

14:50 – 15:30 Coffee break and poster session (posters attached below)
 

Life science in Gothenburg – the new efforts
moderators: Alesia Tietze & Daniel Bojar

15.30 – 15:50 ”Therapeutic oligonucleotide development at the national OligoNova Hub infrastructure” – Pär Matsson, director OligoNova and Shalini Andersson, AstraZeneca

15:50 – 16:05 “Unraveling the mechanism of nuclear RNA interference” – Aishe Sarshad, WCMTM PI

16:05 – 16:20 “The research infrastructures supporting the DDLS initiative”, Thomas Svensson, Chalmers

16:20 – 16:35 Quantum Computing in Göteborg and in Life 91̽��, Göran Johansson, Chalmers

16:35 – 16:50 Genomic Medicine Sweden, Per Sikora, GMS Väst

16.50 – 17.00 Closing words

WCMTM Open Yearly Event 2021 - January 28

At the Wallenberg Centre for Molecular and Translational Medicine Yearly Open Event 2021, five newly recruited group leaders presented their research. A unique panorama of the exciting and versatile research projects being carried out at WCMTM, through one-minute presentations by team members representing each group of the Centre, were also demonstrated.

PRESENTATIONS:

• Björn Redfors
  "Re-thinking myocardial stunning in acute ischemic heart failure
  - The De-Stun Heart Attacks Program"
• Helena Filipsson Nyström
  "The impact of Graves’ disease in the brain: from if to how? From Clinical Experience to Treatment Recommendations"
• Johan Zelano
  "Translational studies on acquired epilepsy"
• Daniel Bojar
  "Sugar, Sugar – Unraveling the Roles of Glycans in Biology via Machine Learning"
• Aishe Sarshad
  "Nuclear RNA interference in health and disease"

Moderators and organizing committee:
Alesia Tietze, Martin Dalin, Anetta Svitorka Härtlova and Anders Rosengren

Thank you to the over 200 participants and speakers at our yearly event on January 31st! 

Thank you to: 
GUNILLA WESTERGREN-THORSSON, director WCMM at Lund University, who gave her perspectives on the national Wallenberg Centre effort.

PERNILLE LAERKEGAARD HANSEN, professor and head of department of Chronic Kidney Disease at IMED CVRM AstraZeneca, that shared her talk ”We begin with the end”.

HENRIC OLSSON, head of Target 91̽�� IMED RIA AstraZeneca, who shared his experiences from 20 years in drug development and respiratory dieases.

BO SÖDERPALM, professor at the Institute of Neuroscience and physiology and senior consultant at the Sahlgrenska University Hospital, who has been awarded a Swedish Research Council “Proof of Concept” grant, that presented his research "Exploiting brain dopamine systems for treatment of alcohol use disorder“.

And a special thanks to our newly recruited WCMTM fellows and group leaders:

ANETTA HÄRTLOVA SVITORKA
Anetta Svitorka Härtlova has been recruited from the Newcastle University, UK, to the Institute of Biomedicine, and her main research focus is on understanding the role and regulation of immune and inflammatory pathways in the context of ageing and age-related pathologies.
Her talk was entitled "Understanding molecular mechanisms of innate immunity in age-related pathologies"

ALESIA TIETZE
Alesia Tietze has been recruited from the University of Technology in Darmstadt, Germany, to the Institute of Chemistry and Molecular Biology. Alesia's research interest lies in the area of medicinal chemistry with focus on the development of protease-stable peptide analogs derived from bioactive peptides.
The title of her talk was "Chemical synthesis of bioactive peptides & membrane-associated proteins: from drug discovery to bioinspired materials”

VOLKAN SAYIN
Volkan Sayin has been recruited from the New York University School of Medicine, USA, to the Institute of Clinical 91̽��s. Volkan’s research is focusing on uncovering genotype dependent therapeutic vulnerabilities in lung cancer and he has a longstanding interest in redox biology, metabolism and the role of antioxidants in tumor development.
Volkan presented “Targeting metabolic dependencies in subtypes of lung cancer”

MARTIN DALIN, our newest clinical recruitment to Wallenberg Centre, presented his clinical research program within the area of cancer entitled "Circulating tumor DNA in pediatric cancer”.

"I am proud of the collaboration between the various partners. It is now our joint responsibility to ensure that the center is successful."
This was the statement from Vice-Chancellor Pam Fredman at the first Wallenberg Centre for Molecular and Translational Medicine Event on February 7th.

On Tuesday February 7th, the Wallenberg Centre Academy arranged the first of yearly events at the Wallenberg Conference Centre.